Avacta launches SARS-CoV-2 BAMS research test
Affimer-based research assay launched alongside performance data published by Bruker
Affimer-based research assay launched alongside performance data published by Bruker
Join thousands of scientists from around the world as they come together online to discuss the hottest topics and latest technology solutions in the field
Explore our roundup of key considerations for a successful CRISPR/Cas9 experiment
Early surgical treatment of leg ulcers caused by varicose veins improves healing and reduces the risk of the condition coming back
CE mark for MitraClip G4 offers physicians an innovative next-generation system with more options for mitral valve repair using proven clip-based technology
Menu of test solutions for infectious diseases – which already includes COVID-19 – to be expanded, especially in the U.S.
Promega and Incyte intend to work together in the future to develop the Promega OncoMate MSI Assay as a companion diagnostic
The Direct assay is validated on a wide range of specimen types, and can be run in parallel with the Simplexa Flu A/B & RSV Direct Gen II assay
The Proxima spatial analysis software solution integrates image acquisition to data analysis in the secure cloud for rapid access by any user
cPass is first commercially available product to rapidly detect neutralizing antibodies capable of eliminating virus
The new line aims to provide unmatched sensitivity, resolution, speed, and flexibility of colors
Emergency scans captured images of the top of the lungs where a fluffiness known as ‘ground glass opacification’ allowed COVID-19 to be diagnosed
AstraZeneca anticipates entering clinical development in 2021
The technology is said to be superior at identifying cell types in human blood, providing faster and more reliable assessments for clinical decision making
The new Elecsys Anti-SARS-CoV-2 S test can quantitatively measure the level of antibodies against SARS-CoV-2 in patients who have been exposed to the virus
The partnership aims to co-market exosome technology as well as the joint development of new exosome based products